Evidence map›Paper›PMID 41015979›Full record

ArticleThe patient2026

Patients as Partners in Sickle Cell Disease Research in Africa: A Framework for Equitable Patient-Engaged Health Research.

Nchangwi Syntia Munung, Lawrence Osei-Tutu, Arafa Salim Said, Hilda Tutuba, Cynthia Changafu, Solange Mela, Alieu Badara W Sambou, Victoria Nembaware, Emmanuel Chide Okocha, Patience Kuona and 6 more

Abstract read
In one paragraph

Article in The patient, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Nchangwi Syntia MunungDivision of Human Genetics, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. nchangwisyntia@yahoo.com.ORCID 0000-0003-1498-3602
Lawrence Osei-TutuKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Arafa Salim SaidSickle Cell Disease Patients Community of Tanzania, Dar es Salaam, Tanzania.
Hilda TutubaDepartment of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences (MUHAS), Dar es Salaam, Tanzania.
Cynthia ChangafuFoundation for Sickle Cell Anaemia, Lusaka, Zambia.
Solange MelaSickle Cell South Africa, Cape Town, South Africa.
Alieu Badara W SambouThe Gambia Sickle Cell Association, Banjul, Gambia.
Victoria NembawareDivision of Human Genetics, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Emmanuel Chide OkochaHaematology Department, Faculty of Basic Clinical Sciences, College of Health Sciences, Nnamdi Azikiwe University, Awka, Anambra State, Nigeria.
Patience KuonaDepartment of Child, Adolescent and Women's Health, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
Leon TshiloloInstitut de Recherche Biomédicale, CEFA-Monkole, Kinshasa, Democratic Republic of the Congo.
SCD-PAPIR WG
Maya SabatelloDepartment of Medicine, Columbia University Irving Medical Center, New York, USA.
Marsha TreadwellDepartment of Pediatrics/Division of Hematology, University of California San Francisco, San Francisco, USA.
Julie MakaniThe Sickle Cell Program, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Ambroise WonkamDivision of Human Genetics, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. awonkam1@jhmi.edu.

Funding

Sickle Africa Data Coordinating CenterU24HL135600 · NHLBI · UNIVERSITY OF CAPE TOWN · PI MULDER, NICOLA, WONKAM, AMBROISE · 2017 to 2025
$8.6M
Public Understanding of Big data in Genomics Medicine in Africa (PUBGEM-Africa)U01MH127692 · NIMH · UNIVERSITY OF CAPE TOWN · PI MUNUNG, NCHANGWI SYNTIA, WONKAM, AMBROISE · 2021 to 2025
$1.9M
NHGRI NIH HHS U24 HG010733-01NHLBI NIH HHS U24HL135600NIMH NIH HHS U01MH127692
6 · The paper itself

Abstract

backgroundPatient and public involvement (PPI) in health research is gaining global momentum through initiatives such as INVOLVE (UK), the Patient-Centred Outcomes Research Institute (USA), and the Strategy for Patient-Oriented Research (Canada). However, its implementation in Africa remains limited and lacks context-specific guidance. To address this gap, the Sickle Africa Data Coordinating Center supported the development of the Patients as Partners in Sickle Cell Disease Research (SCD-PAPIR) Framework to guide meaningful patient engagement and involvement in SCD research in Africa.

methodsAn iterative, participatory approach was adopted. The process involved the creation of a SCD PAPIR working group comprising SCD patient advocates in 14 African countries; 18 virtual working group meetings, one public webinar, and three in-person workshops. The framework was co-created through facilitated discussions reflecting on prior engagement in SCD research as a patient partner, and best practices for effective patient-researcher collaborations. Patient-only sessions and leadership roles were integrated to ensure safe spaces and to minimise power imbalances.

resultsThe SCD-PAPIR Framework positions SCD patients and their caregivers as citizen researchers. Key to the framework is the principle of subsidiarity, which affirms the agency and experiential knowledge of patients while calling for epistemic humility from researchers. Its core pillars include valuing patient expertise, transparent communication, resource sharing, patient empowerment, collective learning, amplification of patient voice, continuous feedback, and shared benefits. Best practices emphasise two-way communication, addressing power asymmetries, co-learning and patient empowerment, co-ownership of outputs, and formalised PAPIR structures.

conclusionThe SCD-PAPIR Framework provides a contextually grounded model for patient-engaged research in Africa and contributes to efforts to decolonise health research by positioning patients as co-creators of knowledge, and not merely a data source. The effective implementation of the framework will require investment in institutionalising PAPIR in SCD research. Future work should focus on designing implementation toolkits, developing PPI training modules for researchers and patient advocates, and adapting the framework to other health conditions.

Indexed as

Anemia, Sickle CellBiomedical ResearchPatient ParticipationAfricaFemaleHumans

Identifiers

PMID41015979
PMCPMC12935701

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.